Member Info for Bobber69

Turner Pope are going to look like absolute mugs at the end of the year when the SP is nowhere near the 6p range they predicted in their most recent broker note (Jan/Feb '26), when they just happened to be selling the placing.

The fact that APTA haven't replaced them says as much about the company as it does the duplicitous broker.

Maybe they should advertise for a BDM considering only £190k (RNS - 29th Jan) of a 'Strong sales pipeline of £3.1 million' (RNS - 7th Jan) has been realised!

The BOD have kicked the can down the road on the majority of their near term programmes of work, probably inline with Tak's projections; So any value in the SP goes with it. This may even drop back to the previous placing price.

ALL loss making AIM companies need regular news flow to sustain the value of the company. If a vacuum is created the value will inevitably ebb away as investors lose interest. There's nothing going other than investor apathy.

They've got their salaries sorted for another year and no placing to sell until next year. No news for a while now......... probably inline with Tak's post..........so despite what they say about cash position, at least one or two placings will be necessary IMO.

Just look at how many new FFS contracts have been signed recently.........none.

How they've come to that conclusion about cash until 2028 doesn't stack up.

The longer it takes, the more dilutions you will have to wear. Hope you've got deep pockets to go with your low expectations.

The cash 'til June 2027 statement was a smokescreen for the last fundraise. There's no reason to believe the latest BS about cash balance 'til 2028 will be any different.

In one fell swoop, this has gone from one of the best investment cases on AIM, to one of the worst.

IMO, I don't think deodorant usage will reduce based upon rising household costs.

If they delay, they risk losing first mover advantage. If a rival gets their product out first, you're then playing catch up.

I'd have thought we would've heard about on person testing success by now. It had been touted as being in progress since late last year.

Next news will probably be results in July. The placing has killed everything stone dead. The results will show a loss of ~£1.5m so they'll probably want that out of the way before any news is released.

I'd be more concerned about the big red ones! 😂

Based your last post, can you elaborate on this statement........'We have a few hours left prior to an update.....my view.....stock up while the SP is low'.

Sounds to me like you were trying to pull the wool over people's eyes. I think you do need to stay out for a while.

Any AZ agreement will come after the AI driven in Vivo work. That's been kicked down the road as a result of the recent placing. Doubt we'll hear about that until end of the year now.

Unilever.......on person testing has probably been going on for six months now. They don't work fast. I'm not expecting that to come soon. It would also highlight the poor timing of the placing, if so.

The best bet is another Twist Bio type deal. 🤷

At least the trades are in favour buys so far today £4.87 v £3.20! 😂😂😂

I mean, 3.5billion shares in circulation is now a bit of a joke for a company this size too. It's a dilution red flag.

I don't post on ADVFN.

I don't really care what you think of me. I just don't want the BOD and TP to have the shirt off my back, because they weren't held accountable.

Ask Adam about his VAL experience where everyone trusted what the BOD were telling PIs until it was too late. There was zero accountability and they took the p1$$.

Which royalty agreements are these Tak?

Any news associated with 'big' diseases are well off. The placing confirmed that.

What makes you think there's going to be an update (trading?) ?

The FY26 results are going to show a revenue of ~£1.5m, which is an annual loss of about as much. Yet the BOD have been handsomely rewarded for this in the placing. Bizarre.

By all means get to the point where the business is at least breaking even and reward yourself. But while losing about £1.5m per year, that's just plain unjustified and typical of AIM.

The AI need shouldn't affect FFS work or other licencing deals like the ones already signed. This news has dropped off a cliff.

I don't think the Unilever work should need AI input either. What's going on there? 🤷

The BOD and Turner Pope have torpedoed all the good momentum from last year. Really poor.

Wow. Nobody sees any value below placing price. Well done all involved in the placing. 👍

It was the late reported UT from yesterday. It was always likely to show this 'drop' if there was no buying pressure this morning.

We are effectively level IMO.

I'm looking forward to the next Turner Pope Brokers Note reiterating the potential 6p SP by the end of the year, if the news flow increases from non-existent. 😂

Obviously, they (conveniently?) released that note as they were selling the recent 0.6p placing so it might need some tweaking. 😂